ALLOSKIN™ meshed human dermal graft, from Allosource Tissue Bank, is available (on the national contract) in both cryopreserved and ambient temperatures.  Please see the below summary and attached brochures for more details.  

Allosource Tissue Bank is one of the world’s largest providers of skin allografts

ALLOSKIN™ is a meshed human dermal graft with broad clinical applications for acute and chronic wound therapy (see references in brochure).  Skin allografts mechanically protect the wound and provide biologic factors native to human skin, which may help stimulate the wound healing process

• • ALLOSKIN™ – cellular and cryopreserved storage

  • ALLOSKIN™ RT – proteins, sterilized, and room-temperature storage

  • ALLOSKIN™ AC – acellular, sterilized, and room-temperature storage

Available in both a ready-to-use, shelf-stable graft with room temperature storage or cryopreserved; both options are designed to accommodate your facility’s needs 

Pliable and stretchable, AlloSkin™ allows for graft contouring to mirror wound topography, while robust enough to suture or staple the graft without tearing

1:1 meshing encourages exudate drainage from wound, allowing the graft to be secured to the surface and avoid “floating.” 

The Natural Solution for Soft Tissue Reconstruction

AlloMend Duo Acellular Dermal Matrix (ADM) is a human-derived, non-directional allograft that incorporates into surrounding tissue and provides a scaffold for cell repopulation and regeneration of the natural host tissues. This deep reticular dermal allograft is used for soft tissue reconstruction, helping surgeons repair and reconstruct soft tissue defects for long-term structural support.

PROCHONDRIX® CR is a Single-Stage, Natural Solution for Patients in Need of Articular Cartilage Repair

• The extracellular matrix helps support a structure for cellular migration and adhesion while preserving native growth factors.

• Presence of native growth factors help maintain healthy cartilage and facilitate chondrocyte functionality.

• Viable chondrocytes are present and can aid in cartilage repair by generating extracellular matrix proteins that help promote chondrogenesis.

Cryopreserved, split-thickness human dermis allografts from AlloSource are temporary dressings targeted toward burn management that contain viable cells and biologic factors native to human skin. These allografts are used with critical burn patients to aid in infection control, fluid maintenance and pain control, as well as to conserve the use of precious autograft skin. The use of skin allografts in the management of burn wounds allows early excision and wound covering which may aid in the overall clinical management of the patient. Split-thickness skin allografts provide a crucial bridge to reconstruction, particularly for large total body surface area (TBSA) burns, which may be closed in a delayed manner. 

• AlloSource is a not-for-profit tissue bank and is one of the world’s largest providers of skin allografts

• PureSkin™ and PureSkin™ XL Split-Thickness Dermis protect the wound bed from exposure, providing infection control

• Native dermal growth factors remain present to aid in the healing process potentially accelerating granulation to support wound closure

• Processed to maximize allograft area, minimizing “patchworking” of smaller pieces in clinical settings

• Choice of meshed allografts to save valuable OR time, or non-meshed allografts to allow custom adaptability (e.g., “pie crusting” or larger meshing patterns) at site

• Meshing allows exudate management, flexibility for diverse anatomical coverage, and expansion as needed

• These allografts are produced using a controlled rate freezing process and cryoprotectants to optimize shelf-life

• PureSkin™ XL is an extra-large allograft (available in sizes up to 1800cm2), which can save valuable OR time and reduce patient time under anesthesia in large TBSA burns, potentially reducing patient trauma with decreased suturing or stapling